(1R,2R,4R)-2-(hex-5-en-1-yl(methyl)carbamoyl)-4-hydroxycyclopentane carboxylic acid

We are (1R,2R,4R)-2-(hex-5-en-1-yl(methyl)carbamoyl)-4-hydroxycyclopentane carboxylic acid CAS:922727-92-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 922727-92-2
Product Name: (1R,2R,4R)-2-(hex-5-en-1-yl(methyl)carbamoyl)-4-hydroxycyclopentane carboxylic acid
Other Name:
(1R,2R,4R)-2-(hex-5-en-1-yl(methyl)carbamoyl)-4-hydroxycyclopentane carboxylic acid
(1R,2R,4R)-2-[5-Hexen-1-yl(methyl)carbamoyl]-4-hydroxycyclopentanecarboxylic acid
(1R,2R,4R)-2-(hex-5-enyl-methyl-carbamoyl)-4-hydroxy-cyclopentanecarboxylic acid
 
Density: 1.2±0.1 g/cm3
Boiling Point: 480.1±45.0 °C at 760 mmHg
Molecular Formula: C14H23NO4
Molecular Weight: 269.337
Flash Point: 244.2±28.7 °C
Exact Mass: 269.162720
PSA: 77.84000
LogP: 0.38
Vapour Pressure: 0.0±2.7 mmHg at 25°C
Index of Refraction: 1.530
 
Specification
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Simeprevir CAS: 923604-59-5.
Be used as pharmaceutical intermediate, mainly used to synthesize antihepatitis C drugs Simeprevir.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

 (1R,2R,4R)-2-(hex-5-en-1-yl(methyl)carbamoyl)-4-hydroxycyclopentane carboxylic acid


Related News: The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.536760-29-9 The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.Catechol CAS:120-80-9 The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.(3S, 4R) -4-Acetoxi-3 – [(R) -1- (terc-butildimetilsililoxi) etil] azetidin-2-ona CAS:76855-69-1 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.

Related Products
Product Name
2-Phosphonobutane -1,2,4-Tricarboxylic Acid View Details
Methyl 2-Amino-4-Bromobenzoate View Details
Ethyl 4-oxocyclohexanecarboxylate View Details
1-Fluoro-3-bromopropane manufacturer 4-Chlorobenzophenone manufacturer 6-Fluoronicotinic acid manufacturer (2-bromo-5-fluorophenyl)methanol manufacturer UDP-α-D-glucuronic acid manufacturer